Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
13.91
+0.08 (0.58%)
At close: Sep 4, 2026, 4:00 PM EDT
13.45
-0.46 (-3.31%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Immix Biopharma Earnings Call Transcripts
Fiscal Year 2025
-
NXC-201 CAR T-cell therapy shows rapid, deep, and durable responses in relapsed/refractory AL amyloidosis, with a favorable safety profile and potential for outpatient use. If approved, it could address a major unmet need for over 20,000 U.S. patients.